tiprankstipranks
Atai Beckley N.V. (ATAI)
NASDAQ:ATAI
US Market
Want to see ATAI full AI Analyst Report?

Atai Beckley N.V. (ATAI) Stock Forecast & Price Target

2,203 Followers
See the Price Targets and Ratings of:

ATAI Analyst Ratings

Strong Buy
11Ratings
Strong Buy
11 Buy
0 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Atai
Beckley N.V.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ATAI Stock 12 Month Forecast

Average Price Target

$14.90
▲(269.73% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Atai Beckley N.V. in the last 3 months. The average price target is $14.90 with a high forecast of $25.00 and a low forecast of $10.00. The average price target represents a 269.73% change from the last price of $4.03.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","13":"$13","26":"$26","6.5":"$6.5","19.5":"$19.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$14.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$10.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,6.5,13,19.5,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.14,5.7446153846153845,7.349230769230768,8.953846153846154,10.558461538461538,12.163076923076922,13.767692307692307,15.372307692307693,16.976923076923075,18.58153846153846,20.186153846153847,21.790769230769232,23.395384615384614,{"y":25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.14,4.967692307692308,5.795384615384616,6.623076923076923,7.450769230769231,8.278461538461539,9.106153846153846,9.933846153846154,10.761538461538462,11.58923076923077,12.416923076923077,13.244615384615386,14.072307692307692,{"y":14.9,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.14,4.59076923076923,5.041538461538462,5.492307692307692,5.943076923076923,6.3938461538461535,6.844615384615384,7.295384615384616,7.746153846153846,8.196923076923078,8.647692307692306,9.098461538461539,9.54923076923077,{"y":10,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.47,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.49,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.71,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.17,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.59,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.2,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.84,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.84,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.09,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.84,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.68,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.7,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.14,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$25.00Average Price Target$14.90Lowest Price Target$10.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ATAI
H.C. Wainwright
H.C. Wainwright
$25
Buy
520.35%
Upside
Reiterated
05/14/26
H.C. Wainwright Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI)
TD Cowen Analyst forecast on ATAI
TD Cowen
TD Cowen
Buy
Reiterated
05/13/26
Clear FDA Path and Phase 3 Advancement of BPL003 Underpin Buy Rating on atai, With Strong Cash Runway Through 2029
Needham Analyst forecast on ATAI
Needham
Needham
$15
Buy
272.21%
Upside
Assigned
05/13/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
JonesTrading Analyst forecast on ATAI
JonesTrading
JonesTrading
$16
Buy
297.02%
Upside
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (NASDAQ: ATAI), Immunic (NASDAQ: IMUX) and Protara Therapeutics (NASDAQ: TARA)
Canaccord Genuity Analyst forecast on ATAI
Canaccord Genuity
Canaccord Genuity
$15
Buy
272.21%
Upside
Reiterated
05/13/26
Canaccord Genuity Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI)
Berenberg Bank Analyst forecast on ATAI
Berenberg Bank
Berenberg Bank
$13$14
Buy
247.39%
Upside
Reiterated
04/20/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Guggenheim Analyst forecast on ATAI
Guggenheim
Guggenheim
$11$16
Buy
297.02%
Upside
Reiterated
04/16/26
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY) and Atai Beckley N.V. (NASDAQ: ATAI)
Oppenheimer Analyst forecast on ATAI
Oppenheimer
Oppenheimer
$14$16
Buy
297.02%
Upside
Assigned
04/05/26
Analysts Are Bullish on These Healthcare Stocks: Atai Beckley N.V. (ATAI), MapLight Therapeutics, Inc. (MPLT)
Deutsche Bank  Analyst forecast on ATAI
Deutsche Bank
Deutsche Bank
$12
Buy
197.77%
Upside
Initiated
03/26/26
AtaiBeckley initiated with a Buy at Deutsche BankAtaiBeckley initiated with a Buy at Deutsche Bank
Maxim Group
$10
Buy
148.14%
Upside
Assigned
03/17/26
AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating
Jefferies Analyst forecast on ATAI
Jefferies
Jefferies
$10
Buy
148.14%
Upside
Reiterated
03/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Aegis Capital Analyst forecast on ATAI
Aegis Capital
Aegis Capital
$8
Buy
98.51%
Upside
Reiterated
07/02/25
Aegis Capital Remains a Buy on ATAI Life Sciences (ATAI)
Lucid Capital Analyst forecast on ATAI
Lucid Capital
Lucid Capital
$12
Buy
197.77%
Upside
Initiated
06/06/25
Atai Life Sciences initiated with a Buy at Lucid CapitalAtai Life Sciences initiated with a Buy at Lucid Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ATAI
H.C. Wainwright
H.C. Wainwright
$25
Buy
520.35%
Upside
Reiterated
05/14/26
H.C. Wainwright Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI)
TD Cowen Analyst forecast on ATAI
TD Cowen
TD Cowen
Buy
Reiterated
05/13/26
Clear FDA Path and Phase 3 Advancement of BPL003 Underpin Buy Rating on atai, With Strong Cash Runway Through 2029
Needham Analyst forecast on ATAI
Needham
Needham
$15
Buy
272.21%
Upside
Assigned
05/13/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
JonesTrading Analyst forecast on ATAI
JonesTrading
JonesTrading
$16
Buy
297.02%
Upside
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (NASDAQ: ATAI), Immunic (NASDAQ: IMUX) and Protara Therapeutics (NASDAQ: TARA)
Canaccord Genuity Analyst forecast on ATAI
Canaccord Genuity
Canaccord Genuity
$15
Buy
272.21%
Upside
Reiterated
05/13/26
Canaccord Genuity Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI)
Berenberg Bank Analyst forecast on ATAI
Berenberg Bank
Berenberg Bank
$13$14
Buy
247.39%
Upside
Reiterated
04/20/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Guggenheim Analyst forecast on ATAI
Guggenheim
Guggenheim
$11$16
Buy
297.02%
Upside
Reiterated
04/16/26
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY) and Atai Beckley N.V. (NASDAQ: ATAI)
Oppenheimer Analyst forecast on ATAI
Oppenheimer
Oppenheimer
$14$16
Buy
297.02%
Upside
Assigned
04/05/26
Analysts Are Bullish on These Healthcare Stocks: Atai Beckley N.V. (ATAI), MapLight Therapeutics, Inc. (MPLT)
Deutsche Bank  Analyst forecast on ATAI
Deutsche Bank
Deutsche Bank
$12
Buy
197.77%
Upside
Initiated
03/26/26
AtaiBeckley initiated with a Buy at Deutsche BankAtaiBeckley initiated with a Buy at Deutsche Bank
Maxim Group
$10
Buy
148.14%
Upside
Assigned
03/17/26
AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating
Jefferies Analyst forecast on ATAI
Jefferies
Jefferies
$10
Buy
148.14%
Upside
Reiterated
03/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Aegis Capital Analyst forecast on ATAI
Aegis Capital
Aegis Capital
$8
Buy
98.51%
Upside
Reiterated
07/02/25
Aegis Capital Remains a Buy on ATAI Life Sciences (ATAI)
Lucid Capital Analyst forecast on ATAI
Lucid Capital
Lucid Capital
$12
Buy
197.77%
Upside
Initiated
06/06/25
Atai Life Sciences initiated with a Buy at Lucid CapitalAtai Life Sciences initiated with a Buy at Lucid Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Atai Beckley N.V.

3 Months
Success Rate
10/13 ratings generated profit
77%
Average Return
+27.49%
Copying Michael Okunewitch's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +27.49% per trade.
1 Year
Success Rate
10/13 ratings generated profit
77%
Average Return
+51.37%
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +51.37% per trade.
2 Years
Success Rate
11/13 ratings generated profit
85%
Average Return
+61.35%
Copying Michael Okunewitch's trades and holding each position for 2 Years would result in 84.62% of your transactions generating a profit, with an average return of +61.35% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ATAI Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
16
15
23
27
25
Buy
2
0
1
2
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
15
24
29
28
In the current month, ATAI has received 28 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ATAI average Analyst price target in the past 3 months is 14.90.
Each month's total comprises the sum of three months' worth of ratings.

ATAI Financial Forecast

ATAI Earnings Forecast

Next quarter’s earnings estimate for ATAI is -$0.11 with a range of -$0.18 to -$0.07. The previous quarter’s EPS was ―. ATAI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year ATAI has its overall industry.
Next quarter’s earnings estimate for ATAI is -$0.11 with a range of -$0.18 to -$0.07. The previous quarter’s EPS was ―. ATAI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year ATAI has its overall industry.

ATAI Sales Forecast

Next quarter’s sales forecast for ATAI is $217.00K with a range of $0.00 to $954.00K. The previous quarter’s sales results were ―. ATAI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year ATAI has its overall industry.
Next quarter’s sales forecast for ATAI is $217.00K with a range of $0.00 to $954.00K. The previous quarter’s sales results were ―. ATAI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year ATAI has its overall industry.

ATAI Stock Forecast FAQ

What is ATAI’s average 12-month price target, according to analysts?
Based on analyst ratings, Atai Beckley N.V.’s 12-month average price target is 14.90.
    What is ATAI’s upside potential, based on the analysts’ average price target?
    Atai Beckley N.V. has 269.73% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ATAI a Buy, Sell or Hold?
          Atai Beckley N.V. has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Atai Beckley N.V.’s price target?
            The average price target for Atai Beckley N.V. is 14.90. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $25.00 ,the lowest forecast is $10.00. The average price target represents 269.73% Increase from the current price of $4.03.
              What do analysts say about Atai Beckley N.V.?
              Atai Beckley N.V.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of ATAI?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.